We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy and are not allowing patients to have people with them during appointments. This is just one more way of ensuring your safety and that of our staff. Read more
The Treatment of Type 2 Diabetes: Challenges and Opportunities
Tea will be served at 3:45 pm.
This program is open to the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Sanders Tri-Institutional Chemical Biology Program
Dr. Michael Foley (TDI)
Advisor to Pharmaceutical Industry
*Former SVP and Franchise Head for Diabetes and Endocrinology
Merck Research Laboratories